Rankings
▼
Calendar
BDX Q2 2020 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena
BDX
Becton, Dickinson and Company
$59B
Q2 2020 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$4.3B
+1.4% YoY
Gross Profit
$1.7B
40.7% margin
Operating Income
$370M
8.7% margin
Net Income
$183M
4.3% margin
EPS (Diluted)
$0.53
QoQ Revenue Growth
+0.7%
Cash Flow
Operating Cash Flow
$482M
Free Cash Flow
$260M
Stock-Based Comp.
$59M
Balance Sheet
Total Assets
$53.5B
Total Liabilities
$32.6B
Stockholders' Equity
$21.0B
Cash & Equivalents
$2.4B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.3B
$4.2B
+1.4%
Gross Profit
$1.7B
$2.0B
-12.2%
Operating Income
$370M
$136M
+172.1%
Net Income
$183M
$20M
+815.0%
Revenue Segments
Medical
$2.2B
51%
Life Sciences
$1.1B
26%
Interventional
$990M
23%
Geographic Segments
UNITED STATES
$2.4B
57%
Non-US
$1.8B
43%
← FY 2020
All Quarters
Q3 2020 →